Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Lundgren

Showing results (321-330 of 681) with videos related to

Pageof 69
Sort By:
The Journal of Infectious Diseases|December 16, 2017
Serum Albumin as a Prognostic Marker for Serious Non-AIDS Endpoints in the Strategic Timing of Antiretroviral Treatment (START) StudyAndreas Ronit, Shweta Sharma, Jason V Baker, et al.
Respiratory Medicine|August 28, 1999
Pneumocystis carinii pneumonia in HIV-infected patients: effect of steroid therapy on surfactant levelJ R Dichter, J D Lundgren, T L Nielsen, et al.
Circulation|June 21, 2008
Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapyJudith S Currier, Jens D Lundgren, Andrew Carr, et al.
The Journal of Infectious Diseases|August 19, 2000
The danish protease inhibitor study: a randomized study comparing the virological efficacy of 3 protease inhibitor-containing regimens for the treatment of human immunodeficiency virus type 1 infectionT L Katzenstein, O Kirk, C Pedersen, et al.
AIDS (London, England)|March 10, 2001
Clinical correlation of variations in the internal transcribed spacer regions of rRNA genes in Pneumocystis carinii f.sp. hominisJ Helweg-Larsen, C H Lee, S Jin, et al.
Plos Computational Biology|January 3, 2023
Deep-sequencing of viral genomes from a large and diverse cohort of treatment-naive HIV-infected persons shows associations between intrahost genetic diversity and viral loadMigle Gabrielaite, Marc Bennedbæk, Malthe Sebro Rasmussen, et al.
HIV Medicine|April 11, 2008
Loss to follow-up in an international, multicentre observational studyA Mocroft, O Kirk, P Aldins, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 22, 2019
Risk Factors for Low CD4+ Count Recovery Despite Viral Suppression Among Participants Initiating Antiretroviral Treatment With CD4+ Counts > 500 Cells/mm3: Findings From the Strategic Timing of AntiRetroviral Therapy (START) TrialJeffrey A Boatman, Jason V Baker, Sean Emery, et al.
Scandinavian Journal of Infectious Diseases|November 27, 1999
Saquinavir hard gel suppresses viral load insufficiently in HIV-infected patients naive to anti-retroviral therapy: a retrospective cohort studyS Jensen-Fangel, O Kirk, L Larsen, et al.
The Journal of Infectious Diseases|January 5, 2008
Impact of bacteremia on the pathogenesis of experimental pneumococcal meningitisChristian T Brandt, David Holm, Matthew Liptrot, et al.
Pageof 69

Showing results (321-330 of 681) with videos related to

Sort By:
Pageof 69
The Journal of Infectious Diseases|December 16, 2017
Serum Albumin as a Prognostic Marker for Serious Non-AIDS Endpoints in the Strategic Timing of Antiretroviral Treatment (START) StudyAndreas Ronit, Shweta Sharma, Jason V Baker, et al.
Respiratory Medicine|August 28, 1999
Pneumocystis carinii pneumonia in HIV-infected patients: effect of steroid therapy on surfactant levelJ R Dichter, J D Lundgren, T L Nielsen, et al.
Circulation|June 21, 2008
Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapyJudith S Currier, Jens D Lundgren, Andrew Carr, et al.
The Journal of Infectious Diseases|August 19, 2000
The danish protease inhibitor study: a randomized study comparing the virological efficacy of 3 protease inhibitor-containing regimens for the treatment of human immunodeficiency virus type 1 infectionT L Katzenstein, O Kirk, C Pedersen, et al.
AIDS (London, England)|March 10, 2001
Clinical correlation of variations in the internal transcribed spacer regions of rRNA genes in Pneumocystis carinii f.sp. hominisJ Helweg-Larsen, C H Lee, S Jin, et al.
Plos Computational Biology|January 3, 2023
Deep-sequencing of viral genomes from a large and diverse cohort of treatment-naive HIV-infected persons shows associations between intrahost genetic diversity and viral loadMigle Gabrielaite, Marc Bennedbæk, Malthe Sebro Rasmussen, et al.
HIV Medicine|April 11, 2008
Loss to follow-up in an international, multicentre observational studyA Mocroft, O Kirk, P Aldins, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 22, 2019
Risk Factors for Low CD4+ Count Recovery Despite Viral Suppression Among Participants Initiating Antiretroviral Treatment With CD4+ Counts > 500 Cells/mm3: Findings From the Strategic Timing of AntiRetroviral Therapy (START) TrialJeffrey A Boatman, Jason V Baker, Sean Emery, et al.
Scandinavian Journal of Infectious Diseases|November 27, 1999
Saquinavir hard gel suppresses viral load insufficiently in HIV-infected patients naive to anti-retroviral therapy: a retrospective cohort studyS Jensen-Fangel, O Kirk, L Larsen, et al.
The Journal of Infectious Diseases|January 5, 2008
Impact of bacteremia on the pathogenesis of experimental pneumococcal meningitisChristian T Brandt, David Holm, Matthew Liptrot, et al.
Pageof 69